CEP-701 60mg

DRUG2 trials

Sponsors

Cephalon

Conditions

Leukemia, MyeloidPsoriasis

Phase 2

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

CompletedNCT00030186

CephalonLeukemia, Myeloid

Start: 2002-01-31End: 2003-02-28Updated: 2012-08-23

Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis

CompletedNCT00236119

CephalonPsoriasis

Start: 2005-06-30End: 2007-10-31Updated: 2012-08-23